BE903610A - Dispositifs contenant des implants anabolisants a liberation prolongee - Google Patents

Dispositifs contenant des implants anabolisants a liberation prolongee

Info

Publication number
BE903610A
BE903610A BE1/011375A BE1011375A BE903610A BE 903610 A BE903610 A BE 903610A BE 1/011375 A BE1/011375 A BE 1/011375A BE 1011375 A BE1011375 A BE 1011375A BE 903610 A BE903610 A BE 903610A
Authority
BE
Belgium
Prior art keywords
implants
sustained release
devices containing
anabolizing
containing sustained
Prior art date
Application number
BE1/011375A
Other languages
English (en)
Original Assignee
Ct De Rech S Biolog Virbac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct De Rech S Biolog Virbac filed Critical Ct De Rech S Biolog Virbac
Publication of BE903610A publication Critical patent/BE903610A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Abstract

Des dispositifs contenant des implants anabolisants à libération prolongée, sont constitués, d'une matrice solide, à base de polymères insolubles hydrophobes associés à des esters de glycérol, de substances dites de charge et d'une ou plusieurs substances actives. Application : Utilisation comme facteur de croissance hormonal chez les bovidés.
BE1/011375A 1984-11-22 1985-11-08 Dispositifs contenant des implants anabolisants a liberation prolongee BE903610A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8418230A FR2573307B1 (fr) 1984-11-22 1984-11-22 Implants anabolisants a liberation prolongee

Publications (1)

Publication Number Publication Date
BE903610A true BE903610A (fr) 1986-05-09

Family

ID=9310081

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/011375A BE903610A (fr) 1984-11-22 1985-11-08 Dispositifs contenant des implants anabolisants a liberation prolongee

Country Status (9)

Country Link
AU (1) AU585280B2 (fr)
BE (1) BE903610A (fr)
DE (1) DE3539408A1 (fr)
FR (1) FR2573307B1 (fr)
GB (1) GB2167662B (fr)
IT (1) IT1188195B (fr)
NL (1) NL8503227A (fr)
NZ (1) NZ214179A (fr)
ZA (1) ZA858486B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003440A1 (fr) * 1984-01-31 1985-08-15 International Foundation For Biochemical Endocrino Procede de promotion de la croissance et amelioration de la qualite de la viande des animaux de boucherie avec des hormones steroides femelles
US4788062A (en) * 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
US5601835A (en) * 1987-04-29 1997-02-11 Massachusetts Institute Of Technology Polymeric device for controlled drug delivery to the CNS
US5114719A (en) * 1987-04-29 1992-05-19 Sabel Bernhard A Extended drug delivery of small, water-soluble molecules
US4883666A (en) * 1987-04-29 1989-11-28 Massachusetts Institute Of Technology Controlled drug delivery system for treatment of neural disorders
US4846844A (en) * 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
US5035891A (en) * 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
FR2753904B1 (fr) * 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
US6022554A (en) * 1997-12-15 2000-02-08 American Home Products Corporation Polymeric microporous film coated subcutaneous implant
US8052982B2 (en) 1998-07-20 2011-11-08 Peptech Animal Health Pty Limited Bioimplant formulation comprising lecithin and stearin
CA2336879C (fr) * 1998-07-20 2010-06-01 Peptech Limited Compositions a liberation prolongee contenant des peptides, des polypeptides, des proteines ou des acides nucleiques comme principes actifs
US7767708B2 (en) 1998-11-04 2010-08-03 Schering-Plough Animal Health Corp. Growth stimulant compositions
BR9914996A (pt) * 1998-11-04 2001-07-10 Schering Corp Composições estimulantes de crescimento melhorado
US6498153B1 (en) 1998-12-31 2002-12-24 Akzo Nobel N.V. Extended release growth promoting two component composition
JP5184727B2 (ja) 1999-06-11 2013-04-17 ワトソン ファーマシューティカルズ， インコーポレイテッド 女性への非経口アンドロゲンステロイドの投与
AU1756001A (en) * 1999-12-16 2001-06-25 Pharmacia & Upjohn Company Implant composition containing melengestrol acetate and trenbolone acetate
BR0207052A (pt) * 2002-10-15 2004-08-10 Natura Cosmeticos Sa Composição cosmética sólida
US20100144687A1 (en) 2008-12-05 2010-06-10 Glaser Rebecca L Pharmaceutical compositions containing testosterone and an aromatase inhibitor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB215137A (en) * 1923-02-23 1924-05-08 Frank Leslie Gridner Improvements in and relating to adjustable chairs
GB1021924A (en) * 1962-06-22 1966-03-09 Smith Kline French Lab Improvements in or relating to method of preparing sustained release tablets
US3920806A (en) * 1973-05-04 1975-11-18 Merck & Co Inc Growth promoting subcutaneous compositions
FR2239988A1 (en) * 1973-08-08 1975-03-07 Aries Robert Animal hormone implants - comprising a mixt. of hormone and fatty acid ester of hormone
US3978203A (en) * 1974-07-12 1976-08-31 Dynatech Corporation Sustained release of pharmaceuticals from polyester matrices
FI63335B (fi) * 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
US4333919A (en) * 1979-09-12 1982-06-08 Eli Lilly And Company Growth promotant controlled release formulations and method of treatment
US4331652A (en) * 1979-09-12 1982-05-25 Eli Lilly And Company Controlled release parasitic formulations and method

Also Published As

Publication number Publication date
DE3539408A1 (de) 1986-06-05
GB2167662A (en) 1986-06-04
GB2167662B (en) 1988-11-30
FR2573307B1 (fr) 1988-06-10
AU4998285A (en) 1986-05-29
AU585280B2 (en) 1989-06-15
FR2573307A1 (fr) 1986-05-23
GB8527915D0 (en) 1985-12-18
NZ214179A (en) 1989-06-28
IT8522829A0 (it) 1985-11-14
ZA858486B (en) 1986-06-25
NL8503227A (nl) 1986-06-16
IT1188195B (it) 1988-01-07

Similar Documents

Publication Publication Date Title
BE903610A (fr) Dispositifs contenant des implants anabolisants a liberation prolongee
UA29563C2 (uk) Мікрокапсула для тривалого вивільнення фізіологічно активного пептиду
IL93360A (en) Bactericidal/permeability increasing protein or biologically active analogs thereof and pharmaceutical compositions containing them
MY101593A (en) Sustained release preparation.
ATE242633T1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
FR2730423B1 (fr) Agencement d'une grille de retenue d'un materiau actif dans un recipient, et recipient ainsi equipe
ATE209900T1 (de) Wachsumsfaktoren enthaltende gelformulierungen
BR9407560A (pt) Copolimeros elastômeros termoplásticos enxertados com silicone e composiçoes para tratamento dos cabelos e da pele contendo estes copolimeros
DE69634670D1 (de) Aktives anodenmaterial und nichtwässrige sekundärbatterie
BE901667A (fr) Composition analgesique et anti-inflammatoire a base de diphenhydramine, leur preparation et leur utilisation.
IT1208208B (it) Copolimeri solubili e biodegradabili per legare sostanze biologicamente attive.
GR3032673T3 (en) Use of an effective quantitiy of active substances for the treatment of mixed skin.
IT1307829B1 (it) Protesi dentale con mezzi per il rilascio di farmaci o fattorispecifici atti ad impedire l'insorgenza di infezioni e/o promuovere
EP0879056A4 (fr) Modulation de l'expression de la cytokine de th1/th2 par la ribavirine-m(3) et des analogues de la ribavirine-m(3) dans les lymphocytes t actives
RU96116802A (ru) Перевязочный материал
TR199701520T1 (xx) Ac�n�n iyile�tirilmesi i�in analjesik bile�ikleri �reten h�cre soyu.
DK0613368T3 (da) Hudregenererende kosmetisk sammensætning
TR200000249T2 (tr) Bir etki maddesinin deri üzerinden bir organizmaya geçirilmesi ve deri üzerine tatbik işlemine dair transdermal terapötik sistem (TTS)
FR2569987B1 (fr) Dispositif implantable autonome et son utilisation pour l'administration de substances actives dans le corps humain
BR9912566A (pt) Micropartìculas preparadas a partir de copolìmeros de cicloolefinas e sua aplicação para a liberação controlada de substâncias ativas
ATE206911T1 (de) Feste arzneimittelform mit polymerem material verteiltem wirkstoff
MY106238A (en) Solid silicone-based agricultural compositions with biological action
DE69804674T2 (de) Liposomen mit mehrfach verzweigten peptidkonstruktionen zur verwendung gegen hiv
MA21471A1 (fr) Composition de tourrage et son utilisation dans le tourrage et le post-tourrage des peaux animales .
OA09771A (en) Asphodelus composition for increasing white blood cell count.